Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA

Gene editing

Home » Emerging technologies » Gene editing

Cibus Achieves Critical Milestones for Two New Gene-Edited Traits that Increase Productivity for Rice Farmers

Precision gene-edited traits for one of the world’s largest crops to help reduce farmers’ costs, while improving yield and quality February 13, 2020 08:30 AM Eastern Standard Time SAN DIEGO–(BUSINESS...

Beam Therapeutics Announces Multiple Scientific Advances in its Base Editing Technology Platforms

Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products For Therapeutics and Diagnostics

Already the leader in CRISPR-based disease detection, the latest round will drive Mammoth’s robust platform for protein discovery to extend into gene-editing and therapeutics applications SOUTH SAN FRANCISCO, Calif...

Algentech

Algentech Granted US Patent For A Key Genome Editing Technology

Horizon Discovery to Provide Access to Novel Base Editing Technology

Emendo Biotherapeutics Raises $61 Million to Advance Next Generation Genome Editing Therapeutics

Synthego Adopts Good Manufacturing Practices for Highest-Quality Genome Engineering for Clinical Applications

LogicBio Therapeutics Announces Collaboration with Takeda to Develop New Genome Editing Candidate LB-301 for the Treatment of Crigler-Najjar Syndrome

Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

SNIPR BIOME Strengthens Lead in CRISPR-based Medicines to Treat Microbiomes

CRISPR Prime

With CRISPR Prime, gene therapies are one step closer to curing millions

Mammoth Biosciences Strengthens Executive Management With Biotech Veterans, Peter Nell and Ted Tisch

GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery

Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

Cyrus Biotechnology and the Broad Institute of MIT and Harvard Launch Multi-Target Collaboration to Develop Optimized CRISPR Gene Editing Technology